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treated by CABG, as revascularization by PCI failed. We chose to re-operate one patient
with LIMA graft thrombosis by conventional CABG, as the LAD had shown diffuse
arteriosclerotic disease at JOPCAB. Thus, the procedural success rate was 97%. One
month after completed hybrid intervention, we observed no deaths. There was one stroke
on the fourth postoperative day and two procedure-related, but no spontaneous myocar-
dial infarctions.
Conclusion: Our prospective registry documented excellent procedural feasibility and
one-month safety of coronary hybrid revascularization combining JOPCAB with PCI.
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IVUS Guided PCI: Taxus Liberte Post Approval Study
Steven K Rowe
Lester E. Cox Medical Centers, Springfield, MO
Background: Intravascular ultrasound (IVUS) has been used to quantitate coronary
artery disease burden, understand lesion morphology and optimize PCI. Numerous trials
have investigated the impact of IVUS on outcomes of coronary intervention.
Methods: Using 3615 patients from TAXUS Libertç post approval study (December 29,
2009 -March 16, 2011) demographic features, lesion, and procedural characteristics with
and without IVUS guided PCI were evaluated.
Results: IVUS was utilized in 308/3615 patients (8.5%), 8.8% of lesions and 8.5% of
vessels. Patients undergoing IVUS guided PCI more often presented with stable angina
(41.9% versus 29.5% P0.001), de novo lesions (92.9% versus 95.8% P0.017), a history
of multi vessel disease (42.5% versus 34.4% P0.004 ), vessels greater than 3.5mm (17.6%
versus 9.3% P0.001), long lesions greater than 28mm (16.7% versus 12.5% P 0.011),
LAD (46.5% versus 37.0% P0.001). There was no increased IVUS use in patients with
in-stent restenosis, ostial or left main lesions. IVUS was used less frequently in patients
with STEMI (2.6% versus 10.7% P0.001), total occlusion (2.3% versus 11.8%
P0.001), vessels 2.25mm-2.5mm in diameter (15.6% versus 26.8% P0.001), or
patients with thrombus (4.5% versus 9.7% P0.001). Non Q-Wave MI (ARC Defini-
tion) was higher in the IVUS group (5.5 versus 1.9 P0.001).
Conclusions: In this real world registry, IVUS use was more frequent in de novo lesions
with stable angina, large vessels, long lesions, LAD, in the absence of thrombus and
pre-deployment intervention. All cause mortality or myocardial infarction was higher in
the IVUS group, suggesting a sicker population. IVUS appeared underutilized in left
main, ostial, restenosis lesions or small vessels. Further study is needed to define
appropriate use and indication for IVUS in PCI.
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Drug Eluting Stents versus Bare Metal Stents in Non-Insulin Dependent Diabetic
Patients with Large Coronary Arteries
Ahmed Shawky, Sherif Elzahwy
Ain shams university, Cairo, Egypt
Background: It is well known that the risk of restenosis and other adverse cardiac events
with bare metal stents (BMS) is increased with smaller stent diameters especially in
diabetic patients. Drug eluting stents (DES) have a particular benefit in small vessel
disease that been repeatedly shown in several studies; however, whether this benefit occurs
in diabetic patients with stenoses in large coronary arteries, is still not clear.
Objective: To evaluate the 6 months angiographic & clinical outcome of non- insulin
dependent diabetic patients with large coronary vessels undergoing PCI using DES versus
BMS. The objective was to evaluate the 6 months angiographic & clinical outcome of
non- insulin dependent diabetic patients with large coronary vessels undergoing PCI using
DES versus BMS.
Methods: 6 months angiographic follow up & clinical follow-up for the occurrence of
major clinical events were recorded, including death, myocardial infarction (MI), unstable
angina, cerebrovascular accidents and target lesion revascularization (TLR) were per-
formed for a 60 consecutive non- insulin dependent diabetic patients with stenoses in large
coronary arteries, requiring PCI using stents of 3.0 mm or more in diameter . The patients
were divided into 2 groups; Group I : 30 patients who underwent successful PCI using
second generation DES & Group II : 30 patients who underwent successful PCI using
BMS.
Results: Even though there were no statistically significant difference between both
groups in the occurrence of cardiovascular events (death, MI, unstable angina, cerebro-
vascular accidents)there was a significantly lower incidence of angiographic restenosis and
TLR in the DES treated group compared to BMS treated group (2.2% vs. 9.3% P
0.02). There was also a similar incidence of denovo lesions in both groups (6.7% in each
group).
Conclusions: In non- insulin dependent diabetic patients with large coronary arteries,
Second generation DES demonstrated significantly lower 6 months restenosis rate &
TLR compared to BMS, while there was no significant differences in rates of cardiovas-
cular events during 6 months follow up between both of them.
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Background: Limited data exist on contemporary gender-related differences in long-
term outcomes of coronary patients receiving drug eluting stents. In this study we evaluate
men (M) and women (W) differences for 2-year target lesion failure (TLF) in an
unselected consecutive series of patients treated with the everolimus- (EES) and
paclitaxel-eluting (PES) stents at a tertiary medical center.
Methods: Data on 347 consecutive patients (M 220, W 125) stented with the EES and
PES were retrospectively analyzed. The primary endpoint of the study was to compare
gender related outcomes in TLF defined as the combined endpoint of cardiac death, non
fatal myocardial infarction and target lesion revascularization (TLR). Secondary endpoints
included TLR, target vessel failure (TVF), target vessel revascularization (TVR), acute
stent thrombosis (ST) as defined by the academic research consortium (ARC) and cardiac
death. The cine angiograms of the first consecutive 162 patients (M 105, W 57) were
independently reviewed by a cardiologist blinded to clinical outcome and SYNTAX
scoring was performed. Follow-up was achieved using medical records and/or phone calls
and was censored at 2 years. Descriptive analysis was performed on all variables. Univariate
analysis compared the men and women cohorts. Propensity matched analysis was
performed to account for differences between M and W.
Results: M had more prior PCI and restenotic lesions and a higher prevalence of
smoking. They also had longer length of disease and received more stents than W. W
were older and had higher prevalence of prior stroke. Angiographic complexity was
statistically similar between the 2 groups as judged by SYNTAX scoring (M 20.8 13.8,
W 19.7 13.9, p 0.650). At 2 years follow up, TLF was 27.4% and 24.8% (p0.614)
with no statistical difference between TLR (23.3% vs. 21.6%), cardiac death (2.8% vs.
3.2%) and definite and probable stent thrombosis (2.3% vs. 0.0%). Propensity matched
analysis showed a statistically similar TLF and TVF between M and W (20.3  16 vs.
27.5  22 (p0.363) and 28.8  23 vs. 35.5  29 (p0.400) respectively).
Conclusion: In this cohort of patients receiving EES and PES, men and women had
similar outcomes at 2- year follow-up consistent with recent reports in the current era of
PCI.
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Background: Limited data exist on contemporary age-related differences in long-term
outcomes of coronary patients receiving drug eluting stents. In this study we evaluate
differences in outcomes in young ( 65 years) (Y) and elderly ( 65 years) (E) patients
for target lesion failure (TLF) at 2-year follow-up in an unselected consecutive series of
patients treated with the everolimus- (EES) and paclitaxel-eluting (PES) stents at a
tertiary medical center.
Methods: Data on 347 consecutive patients (Y 149; E 198) stented with the EES and
PES were retrospectively analyzed. The primary endpoint of the study was to compare age
related outcomes in TLF defined as the combined endpoint of cardiac death, non fatal
myocardial infarction and target lesion revascularization (TLR). Secondary endpoints
included TLR, target vessel failure (TVF), target vessel revascularization (TVR), acute
stent thrombosis (ST) as defined by the academic research consortium (ARC) and cardiac
death. Analysis was done with number of patients as the denominator. Cine angiograms
of the first consecutive 163 patients (Y 64; E 99) were independently reviewed by a
cardiologist blinded to clinical outcome and SYNTAX scoring was performed. Follow-up
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